Company: LIMN
Filing Date: 2025-06-02
Form Type: 10-Q
Source: 0001410578-25-001388
Chunk: 1

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 10-Q
Item: Part I, Item 1F
Chunk 1
---
Item 1. Financial Statements.

Liminatus Pharma, Inc.

(Succesor to Iris Parent Holding Corp.)

Condensed Consolidated Balance Sheets

​

​​​​​​​​    March 31,    December 31,​​2025​2024​​(Unaudited)​​​Assets ​   ​  Total Assets​$ —​$ —​​​​​​​Liabilities and stockholder's deficit​​​​   Current liabilities:​​​​   Accrued expenses​$ 1,060​$ 805Total liabilities​  1,060​  805Commitments and Contingencies (Note 4)​   ​   ​​​​​​​Stockholder's deficit​   ​   Common stock, $0.0001 par value; 1,000 shares authorized; 100 shares issued and outstanding as of March 31, 2025 and December 31, 2024​  —​  —Additional paid-in capital ​  10​  10Stock subscription receivable​  (10)​  (10)Accumulated deficit​  (1,060)​  (805)Total stockholder's deficit​  (1,060)​  (805)Total liabilities and stockholder's deficit​$ —​$ —

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​